ustekinumab,risankizumab,natalizumab
abbvie,boehringer ingelheim,janssen,biogen
['psoriasis', 'derm', 'natalizumab', 'crohn', 'ustekinumab', 'risan']
our very own opening the first session and lecture at #ecco2023. phenomenal review of sequencing of therapies in crohn s. evidence for first and second line therapies (which include surgery), especially with extra intestinal manifestations &amp; concomitant immune mediated ds 
Board certified gastroenterologist and IBD specialist. Director, Intestinal Ultrasound Program @UChicagoMed @UChicagoIBD 🇮🇱🇺🇸 #IBUS ComCom member